Today: 19 May 2026
Reckitt Benckiser share price hits fresh 52-week high as RKT investors eye CAGNY remarks
19 February 2026
1 min read

Reckitt Benckiser share price hits fresh 52-week high as RKT investors eye CAGNY remarks

London, Feb 19, 2026, 09:07 GMT — Regular session

  • Reckitt’s stock hit 6,514p during early London dealing, marking its highest level in a year.
  • CEO Kris Licht and CFO Shannon Eisenhardt are slated to appear at the CAGNY investor conference Thursday afternoon.
  • Reckitt’s full-year numbers are due March 5, the next major catalyst for the stock.

Shares of Reckitt Benckiser Group plc climbed to a new 52-week high on Thursday, ticking up to 6,514p earlier in the session before easing. By 09:07 GMT, the stock was up 0.1% at 6,482 pence.

The announcement swung attention back to the consumer health and hygiene player, just hours before a planned investor update. Reckitt confirmed CEO Kris Licht and CFO Shannon Eisenhardt are set to appear at the Consumer Analyst Group of New York (CAGNY) conference in Orlando. The company, though, made clear it doesn’t plan to share any fresh material financial or trading details.

CAGNY stands out as a major fixture for consumer staples, drawing investors who are alert to even subtle changes in commentary on demand, pricing, and costs. According to the agenda, Reckitt is scheduled to present right after Procter & Gamble and just before Kimberly-Clark—three big players lined up in quick succession, a sequence that often carries weight for sector mood that day.

Timing’s a factor here—Reckitt’s next set of results isn’t expected for several weeks. According to a company event notice, Reckitt will release its full-year 2025 numbers on March 5, including an investor presentation in London and a webcast for those dialing in remotely.

Reckitt’s gains come as UK blue chips draw fresh attention following the FTSE 100’s record finish on Wednesday. “Investors keep piling into UK assets,” wrote Axel Rudolph, senior financial analyst at IG, citing a gap in UK versus U.S. valuations. Reuters

Thursday’s session kicked off with a cautious mood. European stocks edged lower, with investors sifting through a batch of mixed earnings and keeping a wary eye on escalating U.S.-Iran tensions in the Middle East.

Shareholders are closing in on a cash payout that’s been flagged for weeks. Back in January, Reckitt put out an RNS confirming plans for a 235 pence special dividend, scheduled for Feb. 20. The company paired the move with a share consolidation that hit on Feb. 2; after that, the stock went ex-dividend, so anyone buying now misses out on the distribution.

Once CAGNY wraps up, investors get a quick succession of key dates. Reckitt’s financial calendar shows results dropping March 5, then the first-quarter trading update lands April 22.

The near-term picture isn’t one-sided. No new trading update is on the docket for the conference, so shares may end up moving on subtler cues: management’s tone, word choice, even a hint about what they expect for volumes and pricing heading into spring. Broader risk appetite could tip the balance, too.

Stock Market Today

  • Wall Street Raises Nvidia Price Targets Ahead of Strong Q1 Fiscal 2027 Report
    May 19, 2026, 5:19 AM EDT. Nvidia (NVDA) investors received optimistic updates from Wall Street analysts, with Morgan Stanley and KeyBanc raising their price targets to $285 and $300, respectively. Analysts expect robust growth driven by strong sales of Nvidia's Blackwell AI chips, forecasting revenue to hit $79.17 billion for fiscal Q1, representing an 80% year-over-year increase. Nvidia's market cap stands at $5.4 trillion, and Wall Street projects revenue of $372 billion in 2026 and $492 billion in 2027. CEO Jensen Huang expressed confidence in over $1 trillion in revenue from new chip lines, Blackwell and Rubin, reinforcing bullish sentiment ahead of Nvidia's earnings report due Wednesday after market close.

Latest articles

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.
NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

19 May 2026
NextEra Energy shares fell 4.6% to $89.04 late Monday after announcing a $66.8 billion stock-led merger with Dominion Energy, whose shares rose 9.4% to $67.56. The deal would create one of the world’s largest electric utilities, serving about 10 million customer accounts and owning 110 gigawatts of generation across four states.

Popular

IREN Drops Again After AI Cloud Plans Get Costlier

IREN Drops Again After AI Cloud Plans Get Costlier

18 May 2026
IREN shares dropped 7.2% to $49.15 Monday after the company acquired its marketing partner Awaken, folding the agency into its operations. The decline followed IREN’s $3 billion convertible-note sale last week to fund a major data-center expansion for AI services. Quarterly revenue fell and net loss widened as the company shifts from Bitcoin mining to AI cloud infrastructure.
British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running
Previous Story

British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running

German stock market today: DAX slides as Airbus sinks, BASF hit by Barclays cut; Vonovia climbs
Next Story

German stock market today: DAX slides as Airbus sinks, BASF hit by Barclays cut; Vonovia climbs

Go toTop